Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Linenberger

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Transfusion Medicine Reviews|September 25, 2024
ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards'Betty Doggett, Nicole A Aqui, Yvette M Miller, et al.
Transfusion Medicine Reviews|October 15, 2014
Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger SurveyRobert S Makar, Anand Padmanabhan, Haewon C Kim, et al.
Journal of Clinical Apheresis|February 3, 2012
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cellsAjay K Gopal, Mehdi Karami, JoAl Mayor, et al.
Transplantation and Cellular Therapy|September 2, 2023
Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceLaura Connelly-Smith, Ted Gooley, Laura Roberts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2011
Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftmentNandita Khera, Jack Jinneman, Barry E Storer, et al.
Journal of Clinical Apheresis|October 17, 2018
Choosing Wisely for apheresisLaura Connelly-Smith, Yvette C Tanhehco, Vishesh Chhibber, et al.
American Journal of Clinical Pathology|July 18, 2015
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric PatientsMin Fang, Pamela S Becker, Michael Linenberger, et al.
Journal of Clinical Apheresis|January 15, 2016
Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommitteeMandy Flannery O'Leary, Nancy M Dunbar, Haewon C Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety StudyGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Transfusion Medicine Reviews|September 25, 2024
ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards'Betty Doggett, Nicole A Aqui, Yvette M Miller, et al.
Transfusion Medicine Reviews|October 15, 2014
Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger SurveyRobert S Makar, Anand Padmanabhan, Haewon C Kim, et al.
Journal of Clinical Apheresis|February 3, 2012
The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cellsAjay K Gopal, Mehdi Karami, JoAl Mayor, et al.
Transplantation and Cellular Therapy|September 2, 2023
Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceLaura Connelly-Smith, Ted Gooley, Laura Roberts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2011
Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftmentNandita Khera, Jack Jinneman, Barry E Storer, et al.
Journal of Clinical Apheresis|October 17, 2018
Choosing Wisely for apheresisLaura Connelly-Smith, Yvette C Tanhehco, Vishesh Chhibber, et al.
American Journal of Clinical Pathology|July 18, 2015
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric PatientsMin Fang, Pamela S Becker, Michael Linenberger, et al.
Journal of Clinical Apheresis|January 15, 2016
Venous access for hematopoietic progenitor cell collection: An international survey by the ASFA HPC donor subcommitteeMandy Flannery O'Leary, Nancy M Dunbar, Haewon C Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety StudyGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Transplantation and Cellular Therapy|April 10, 2021
Serious Adverse Events in Related Donors: A Report from the Related Donor Safe StudyMatthew D Seftel, Pintip Chitphakdithai, John P Miller, et al.
Pageof 3